Odysight.ai Reports Full Year 2025 Results with 23% Core Revenue Growth, $26M Cash, and Strategic Milestones
summarizeSummary
Odysight.ai reported full year 2025 results, showcasing a strategic pivot to aerospace, defense, and industrial markets with 23% core revenue growth, a $13.8 million backlog, and a strong $26 million cash balance, despite a wider net loss due to investment.
check_boxKey Events
-
Strategic Business Transition Underway
The company successfully transitioned from its legacy medical business to focus entirely on high-value aerospace, defense, and industrial sectors, with core vision-based PdM/CBM platform revenues growing approximately 23% year-over-year.
-
Strong Liquidity and Backlog
Odysight.ai ended 2025 with a robust cash balance of approximately $26 million and no debt, providing a strong foundation for ongoing operations. The company reported a backlog of approximately $13.8 million as of December 31, 2025, offering revenue visibility into 2026 and beyond.
-
Significant Operational Milestones Achieved
Key achievements include delivering systems for UAVs under a contract with a Top 25 global defense contractor, successful technology demonstrations with the Italian Air Force, new pilot orders for combat helicopter monitoring, and expanding into industrial markets with a commercial purchase order for elevator belt monitoring systems.
-
Increased Investment Leads to Wider Net Loss
Total revenues for 2025 were $3.0 million (down from $4.0 million in 2024), primarily due to the wind-down of a legacy medical contract. Operating expenses increased to $19.0 million (from $13.7 million in 2024) reflecting strategic investments in product development, global market expansion, and infrastructure, resulting in a net loss of $17.0 million.
auto_awesomeAnalysis
Odysight.ai Inc. reported full year 2025 results highlighting a strategic transition from its legacy medical business to focus on high-value aerospace, defense, and industrial sectors. Despite a wider net loss due to increased investment in product development and global expansion, the company achieved a 23% year-over-year growth in its core vision-based PdM/CBM platform revenues. A strong cash balance of $26 million and a $13.8 million backlog provide significant liquidity and revenue visibility. Investors should note the numerous strategic milestones, including new contracts and partnerships, which underscore the company's progress in its target markets and its exploration of a dual listing on the TASE to broaden investor access.
At the time of this filing, ODYS was trading at $6.39 on NASDAQ in the Technology sector, with a market capitalization of approximately $104.6M. The 52-week trading range was $2.60 to $7.02. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.